Qualigen Therapeutics
Price & Volume
Stats
See more52W Range | $2.85-$29.43 |
Market Cap | $2.6M |
Shares Short | 51,262 |
Financials
See moreRevenue (12 Mos) | $4.9M |
Revenue Growth (YoY) | 13.7% |
Gross Profit (12 Mos) | -$2.5M |
Diluted EPS | $3,635 |
News
See moreYahoo Finance • last year
Qualigen Therapeutics Provides Corporate Update for Third Quarter and To Date 2023
Yahoo Finance • last year
Qualigen Therapeutics Announces First Patient Dosed in the Phase 1a Clinical Trial of QN-302 for Treatment of Advanced or Metastatic Solid Tumors
Yahoo Finance • 2 years ago
Poster Highlighting Qualigen Therapeutics' Pan-RAS Inhibitor Platform Presented at AACR Special Conference: Advances in Breast Cancer
Yahoo Finance • 2 years ago
Qualigen Therapeutics Presents Scientific Data on QN-302 at AACR Special Conference: Pancreatic Cancer 2023
About
CEO | Mr. Kevin A. Richardson II |
CFO | Mr. Kevin A. Richardson II |
Address | 5857 Owens Avenue, Carlsbad, CA, United States, 92008 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 4 |
